BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR NAÏVE PATIENTS WITH ANKYLOSING SPONDYLITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1042
https://www.valueinhealthjournal.com/article/S1098-3015(16)01110-4/fulltext
Title :
BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR NAÏVE PATIENTS WITH ANKYLOSING SPONDYLITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01110-4&doi=10.1016/j.jval.2016.03.1042
First page :
A244
Section Title :
Systemic Disorders/Conditions - Cost Studies
Open access? :
No
Section Order :
891